Dr. Bhutani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
515 Spruce St
San Francisco, CA 94118Phone+1 415-476-4701- Is this information wrong?
Education & Training
- University of California (San Francisco)Chief Residency, Dermatology, 2014 - 2015
- University of California (San Francisco)Residency, Dermatology, 2012 - 2015
- University of California (San Diego) Medical CenterInternship, Preliminary Year, 2008 - 2009
- Keck School of Medicine of the University of Southern CaliforniaClass of 2008
- University of CaliforniaBS, Animal Physiology & Neuroscience, 2004
Certifications & Licensure
- CA State Medical License 2009 - 2024
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- National Psoriasis Foundation Medical Dermatology Research Grant Recipient 2012
- Dean’s Recognition Keck School of Medicine, 2008
- Scholarship for Academic Excellence Keck School of Medicine, 2008
- Join now to see all
Clinical Trials
- Safety and Efficacy Study of Combination Treatment With Excimer Laser, Clobex Spray, and Vectical Ointment in the Treatment of Psoriasis Start of enrollment: 2010 Jun 01
- The Quality of Life Study in Psoriasis Patients After Ustekinumab Treatment Start of enrollment: 2012 Mar 01
- Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis Start of enrollment: 2017 Mar 28
- Join now to see all
Publications & Presentations
PubMed
- Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis.Jayme Heim, Jacob Mathew, Thomas Ferro, J Gabriel Vasquez, Tina Bhutani, John Koo, Neal Bhatia> ;Dermatology and Therapy. 2024 Apr 4
- Comment on 'Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomi...Chandler Johnson, Payton Smith, Kathryn Haran, Allison Kranyak, Wilson Liao, Tina Bhutani> ;The British Journal of Dermatology. 2024 Mar 15
- Clinical and Disease Burden of Patients with Generalized Pustular Psoriasis: A Review of Real-World Evidence.Bhutani, T., Farberg, A.> ;Dermatology and Therapy. 2024 Feb 1
- Join now to see all
Journal Articles
- The Impact of Pediatric Atopic Dermatitis on Families: A ReviewJohn Koo, Tina Bhutani, Pediatric Dermatology
- Dupilumab Treatment for Generalized Prurigo NodularisTina Bhutani, Wilson Liao, JAMA
- Recent Developments in Atopic DermatitisSahil Sekhon, Tina Bhutani, AAP News
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Safe and Effective Treatment of Moderate to Severe Psoriasis using 308nm Excimer Laser, Clobetasol Spray, and Calcitriol Ointment.Bhutani T, The Photomedicine Society 20th Annual Meeting, New Orleans, LA
- Anatomically Differentiated Dosimetry for Optimal Phototherapy of Generalized Psoriasis.Bhutani T, The American Academy of Dermatology Summer Academy Meeting 2011., New York, New York
- Innovative Treatment Option for Moderate-to-Severe Generalized Plaque Psoriasis Using 308nm-UVB Excimer Laser, Clobetasol Spray, and Calcitriol Ointment.Heller MM, Lee ES, Kamangar F, Park K, Bhutani T, and Koo JYM, European Society for Dermatological Research’s 41st Annual Meeting, Barcelona, Spain
- Join now to see all
Lectures
- PhototherapyAmerican Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019
- A Pilot Study Evaluating the Efficacy of Intra-Lesional Amevive.Tokyo, Japan. Astellas Headquarters
- Modern Ultra Goeckerman Therapy.Kasturba Medical College, Manipal, India
Other
- Keratosis Follicularis (Darier Disease).Kwok P, Bhutani T, Liao W, eMedicine from WebMD
http://emedicine.medscape.com/article/1107340-overview.
Authored Content
- Recent Developments in Atopic DermatitisSeptember 2018
Press Mentions
- Megan Mosca on the Impact of Systemic Psoriasis Tx on Cardiometabolic ComorbiditiesDecember 17th, 2021
- STRATA Skin Sciences's (SSKN) CEO Dr. Dolev Rafaeli on Q1 2020 Results - Earnings Call TranscriptMay 12th, 2020
- Luma Therapeutics Announces Positive Clinical Data for the Illuvinate System, a New in-Home Treatment for PsoriasisMarch 6th, 2019
- Join now to see all
Hospital Affiliations
- UCSF Medical CenterSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: